CARCINOMA OF BLADDER: COBALT THERAPY.
D000230:Adenocarcinoma; D000257:Adenoviridae Infections; D002170:Canada; D002277:Carcinoma; D002294:Carcinoma, Squamous Cell; D002295:Carcinoma, Transitional Cell; D003035:Cobalt; D003036:Cobalt Isotopes; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000453:epidemiology* / Q000532:radiotherapy*; D010166:Palliative Care; D011379:Prognosis; D011471:Prostatic Neoplasms; D011867:Radioisotope Teletherapy; D011879:Radiotherapy Dosage; D001749:Urinary Bladder Neoplasms
D003036:Cobalt Isotopes; D003035:Cobalt
ADENOCARCINOMA; ADENOVIRUS INFECTIONS; BLADDER NEOPLASMS; CANADA; CARCINOMA; CARCINOMA, EPIDERMOID; CARCINOMA, TRANSITIONAL CELL; COBALT ISOTOPES; NEOPLASM RADIOTHERAPY; NEOPLASM STATISTICS; PALLIATIVE TREATMENT; PROGNOSIS; PROSTATIC NEOPLASMS; RADIOISOTOPE TELETHERAPY; RADIOTHERAPY DOSAGE